Recursion can feel like magic until you understand its simple rules: a base case to stop, and a recursive call to repeat. By breaking problems into smaller versions of themselves, recursion makes ...

Brighter days - at least days with more sunlight - are ahead. We'll officially gain an extra hour of sunlight when we "spring forward" at 2 a.m. Sunday morning, as daylight saving time starts. As ...

The weather is getting warmer and the days are getting longer in Atlanta, which just means that an hour of the day is about to feel like it's been taken away. Daylight Saving Time is set to kick in ...

The short month of February will soon give way to March, warmer spring weather and the start of daylight saving 2026 time change. Here's when to move the clocks ahead and what to know. Most of the ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

When the sun rises on May 18 in the small Norwegian fishing village of Sommarøy, located above the Arctic Circle, it doesn’t set again until July 26. Later in the year, it vanishes from November until ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Abstract: Time-series forecasting demands efficient modeling of long-range dependencies while maintaining computational practicality. Current methods, particularly deep learning approaches, often ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...